Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Preview: Bioaffinity Technologies, Inc. Set To IPO Tomorrow

bioAffinity Technologies, Inc. (NASDAQ:BIAF) IPO will take place August, 26 on the NASDAQ exchange under the ticker BIAF. The company is offering shares at an expected price between $6.00 and $6.25 per share with an insider lock-up period of 180 days ending on February 22, 2023.
byBenzinga Insights
August 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

bioAffinity Technologies, Inc. (NASDAQ:BIAF) IPO will take place August, 26 on the NASDAQ exchange under the ticker BIAF.

The company is offering shares at an expected price between $6.00 and $6.25 per share with an insider lock-up period of 180 days ending on February 22, 2023.

See also: Benzinga IPO Calendar

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. is a privately held company incorporated in Delaware addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment.

See also: Benzinga’s Most Shorted Stocks

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

September SPAC Merger Calendar: A Look At Upcoming Votes And Stocks To Watch

By Chris Katje
Today, 9:50 PM
The month of September marks a slow down in deal votes after recent months but still offers up several well-known companies that will go public if their SPAC merger votes are approved. SPAC merger votes can act as a catalyst as it completes the last step in the merger process and also changes the company over to a new name and ticker that can help build recognition.

ACIC